Goodwin
Sam Beavers
- Deals
- 2
- Latest
- May 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 2 deals
Often works with
- Felipe M. Heiderich 2 deals together
- Daniel Karelitz 2 deals together
- Malhar Naik 2 deals together
- Arman Oruc 2 deals together
- Kevin Walsh 2 deals together
- Wei Xu 1 deal together
- David R. Chen 1 deal together
- Kingsley L. Taft 1 deal together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| May 2026 | LimmaTech Biologics AG | – | Eli Lilly and Company | Acquisition | Legal adviser to LimmaTech Biologics AG (target) | Pending | 780.0 | Biotech | Eli Lilly and Company acquisition of LimmaTech Biologics AG |
| Mar 2026 | Ouro Medicines | – | Gilead | Acquisition | Legal adviser to Ouro Medicines (target) | Announced | 1,675.0 | Biotech+1 | Gilead acquisition of Ouro Medicines |
Deals where Sam Beavers is named on the firm's deal team, by the firm or the press.